| Original language | English |
|---|---|
| Pages (from-to) | 605-607 |
| Number of pages | 3 |
| Journal | Leukemia |
| Volume | 23 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 1 Jan 2009 |
Cite this
}
Lenalidomide alone or in combination with dexamethasone is highly effective in patients with relapsed multiple myeloma following allogeneic stem cell transplantation and increases the frequency of CD4+Foxp3+ T cells. / Minnema, M. C.; van der Veer, M. S.; Aarts, T.; Emmelot, M.; Mutis, T.; Lokhorst, H. M.
In: Leukemia, Vol. 23, No. 3, 01.01.2009, p. 605-607.Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - Lenalidomide alone or in combination with dexamethasone is highly effective in patients with relapsed multiple myeloma following allogeneic stem cell transplantation and increases the frequency of CD4+Foxp3+ T cells
AU - Minnema, M. C.
AU - van der Veer, M. S.
AU - Aarts, T.
AU - Emmelot, M.
AU - Mutis, T.
AU - Lokhorst, H. M.
PY - 2009/1/1
Y1 - 2009/1/1
UR - http://www.scopus.com/inward/record.url?scp=62549095932&partnerID=8YFLogxK
U2 - 10.1038/leu.2008.247
DO - 10.1038/leu.2008.247
M3 - Article
VL - 23
SP - 605
EP - 607
JO - Leukemia
JF - Leukemia
SN - 0887-6924
IS - 3
ER -